2.31

6.48% -0.16

Pre-market: 2.26 -0.05 -2.16%

Cabaletta Bio Inc (CABA)

Overview News Price History Option Chain Financials Why CABA Down? Discussions Forecast

Cabaletta Bio Inc stock is traded at $2.31, with a volume of 3.48M. It is down -6.48% in the last 24 hours and up +45.28% over the past month. Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Previous Close:

$2.47

Open:

$2.45

24h Volume:

3.48M

Relative Volume:

2.05

Market Cap:

$211.28M

Revenue:

Net Income/Loss:

$-67.68M

P/E Ratio:

-1.3916

EPS:

-1.66

Net Cash Flow:

$-54.24M

1W Performance:

+5.96%

1M Performance:

+45.28%

6M Performance:

+39.16%

1Y Performance:

-41.52%

1-Day Range:

$2.19

$2.4644

1-Week Range:

$2.08

$2.55

52-Week Range:

$0.9857

$5.46

Cabaletta Bio Inc Stock (CABA) Company Profile

Name

Cabaletta Bio Inc

Sector

Healthcare (1143)

Industry

Biotechnology (642)

Phone

(267) 759-3100

Address

2929 ARCH STREET, PHILADELPHIA, PA

Employee

167

Twitter

@CabalettaBio

Next Earnings Date

2025-03-31

Latest SEC Filings

CABA's Discussions on Twitter

Compare CABA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CABA Cabaletta Bio Inc	2.31	225.92M	0	-67.68M	-54.24M	-1.66
VRTX Vertex Pharmaceuticals Inc	381.87	96.56B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	449.58	60.08B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	555.51	61.15B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	711.09	44.66B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	328.71	36.23B	3.81B	-644.79M	-669.77M	-6.24

Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-20-24	Downgrade	Evercore ISI	Outperform → In-line
Dec-19-24	Downgrade	Wells Fargo	Overweight → Equal Weight
Oct-10-24	Initiated	UBS	Buy
Feb-05-24	Initiated	Jefferies	Buy
Nov-29-23	Initiated	William Blair	Outperform
Oct-24-23	Initiated	Cantor Fitzgerald	Overweight
Oct-19-23	Initiated	Stifel	Buy
Sep-05-23	Initiated	Citigroup	Buy
Jul-18-23	Initiated	Guggenheim	Buy
Jan-27-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-30-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Dec-08-21	Initiated	Wells Fargo	Overweight
Oct-19-21	Resumed	Morgan Stanley	Overweight
Jun-30-21	Initiated	Mizuho	Buy
Jan-08-21	Initiated	Chardan Capital Markets	Buy
Oct-13-20	Initiated	H.C. Wainwright	Buy
Nov-19-19	Initiated	Cowen	Outperform
Nov-19-19	Initiated	Evercore ISI	Outperform
Nov-19-19	Initiated	Morgan Stanley	Overweight

View All

Cabaletta Bio Inc Stock (CABA) Latest News

Sep 25, 2025

Volume Recap: Is Cabaletta Bio Inc. stock a top pick in earnings seasonMarket Movers & Stepwise Entry/Exit Trade Alerts - The British Mountaineering Council

Sep 25, 2025

Recent Uptick Might Appease Cabaletta Bio, Inc. (NASDAQ:CABA) Institutional Owners After Losing 37% Over the Past Year - 富途牛牛

Sep 25, 2025

Sep 24, 2025

Cantor Fitzgerald reiterates Overweight rating on Cabaletta Bio stock - Investing.com

Sep 24, 2025

Cantor Fitzgerald reiterates Overweight rating on Cabaletta Bio stock By Investing.com - Investing.com UK

Sep 24, 2025

Sep 22, 2025

How to use Fibonacci retracement on Cabaletta Bio Inc.July 2025 Levels & Low Risk High Reward Trade Ideas - newser.com

Sep 22, 2025

Acadian Asset Management LLC Acquires 182,406 Shares of Cabaletta Bio, Inc. $CABA - MarketBeat

Sep 22, 2025

Sep 21, 2025

What indicators show strength in Cabaletta Bio Inc.Trend Reversal & Expert Verified Stock Movement Alerts - newser.com

Sep 21, 2025

Sep 19, 2025

Short interest data insights for Cabaletta Bio Inc.July 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com

Sep 19, 2025

Pattern recognition hints at Cabaletta Bio Inc. upsideJuly 2025 Retail & Verified Chart Pattern Trade Signals - newser.com

Sep 19, 2025

ETF Watch: Is Cabaletta Bio Inc stock a smart retirement pickRecession Risk & Growth Focused Stock Pick Reports - khodrobank.com

Sep 19, 2025

Market Leaders: Does Cabaletta Bio Inc have pricing powerWeekly Risk Report & Consistent Growth Equity Picks - khodrobank.com

Sep 19, 2025

Geopolitics Watch: Is Cabaletta Bio Inc. stock trending bullishWeekly Trade Analysis & Breakout Confirmation Trade Signals - khodrobank.com

Sep 19, 2025

Sep 18, 2025

Merger Talk: How does TRINI compare to its peersTrade Entry Report & Fast Exit and Entry Trade Guides - خودرو بانک

Sep 18, 2025

Cabaletta Bio Reveals Promising Clinical Data for Autoimmune Therapy - MSN

Sep 18, 2025

Aug Technicals: What’s the beta of Cabaletta Bio Inc. stockQuarterly Earnings Report & High Conviction Trade Alerts - خودرو بانک

Sep 18, 2025

Published on: 2025-09-18 23:16:37 - خودرو بانک

Sep 18, 2025

Sep 17, 2025

Aug Macro: What are Cabaletta Bio Inc.’s recent SEC filings showingMarket Volume Summary & Consistent Income Trade Recommendations - خودرو بانک

Sep 17, 2025

Cabaletta Bio’s SWOT analysis: CAR-T innovator’s stock faces market skepticism - Investing.com

Sep 17, 2025

Sep 16, 2025